FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/10/2026
Back to search
Official data from USPTO
ROUKEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ROUKEN
ST13
US500000079422824Class
1, 5, 42
Filing
79422824
Registration
8164112
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/11/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/26/2024
Registration date
03/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Antibody Analytics Limited
Representatives
Alexandra MacKay Stites & Harbison PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and science; chemicals and reagents for scientific or medical research purposes; chemical preparationssubstances and reagents for analysis in laboratoriesnot for medical or veterinary purposes; diagnostic preparationsnot for medical or veterinary purposes; reagents used for research purposesin particularfor medical research; reagents used for chemical analysesnot for medical or veterinary purposes; scientific reagentsnot for medical or veterinary purposes; chemicals for scientific and research use in the field of immunology; reagents used for scientific and research purposes in the field of immunoserology; diagnostic and testing reagents for scientific usenot for medical or veterinary purposes; immunoassay reagentsother than for medical use; laboratory chemicals and reagents for scientific use and medical research; biochemical reagents used for non-medical purposes; biochemicals being monoclonal antibodies used for non-medical purposes; immunogensimmunoglobulinsantibodiespeptides and proteins for scientific and medical research services; biological activatorspreparations for clinical or medical laboratory use; biological preparations for use as assay samples for research analysis purposes in the field of medical research; reagents for use in scientific apparatus for chemical or biological analysis; biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays used for non-medical purposes; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs used for non-medical purposes; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use for non-medical purposes; reagents for scientific and research use; assays and reagents for use in genetic research; cell culture reagents for scientific and research use; protein for industrial use; protein in raw material form for scientific and medical research; assays for research purposes; biochemicalspolypeptides for in vitro research use; biochemicalsDNARNA and oligonucleotides for in vitro research use; cells for scientific and research use; immune cells for scientific and research use; T cells for scientific and research use; primary cells for scientific and research use; immortalised cells for scientific and research use; biological tissuebloodstem cellsdisease state tissuehealthy donor tissuehealthy donor bloodhuman biopsy tissueumbilical cords and placentas for scientific and medical research use
Class 5
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; biological preparations for medical purposesbiological preparations for the diagnoses and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; large molecules for medical purposes being chemical reagents for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for medical use; diagnostic preparations for medical purposesbiological tissue; biological preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases; biological and chemical preparations and reagents for medical or veterinary use; antiserums for diagnostic purposes for diagnoses of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; diagnostic reagents for medical use; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical use; diagnostic agentspreparations and substances for medical purposes; medical diagnostic reagents and assays for testing body fluids for microorganisms; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; antibodies for medical purposes; in-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; reagents for medical use; chemical reagents for medical purposes; reagents for use in medical genetic testing; enzymes for medical purposes; cells for medical or clinical use; culture media for cultivating human cells and microorganism cells for medical purposes; immunoassay reagents for medical use; assay platforms for medical use for detecting and analysing proteinsnucleic acidssmall moleculescellspathogens and lipids; immunology assays for medical use for detecting and analysing proteinsnucleic acidssmall moleculescellspathogens and lipids; antigens for medical use; antiviral T cells for medical use; human immune cellsin particular T cellsfor medical or clinical purposes; human primary cells for medical and clinical use; immortalised human cells for medical and clinical use; target antigens for medical use; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disorders for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; vaccine preparations; therapeutic vaccines
Class 42
Scientific and medical research and development services for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicotologicrespiratoryneurologicalgastrointestinalpancreaticnephrologicmusculoskeletalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; medical research laboratory services; research and development services in the field of antibodies and antibody technology; advisory services relating to the development of chemical reagents; scientific and industrial research services in the fields of biotechnologypharmaceuticalsimmunologycell engineeringimmunoassays and pharmacogenetics; laboratory services namelyresearchanalysischaracterising and development of therapeutic proteins and human antibodies; development and design of scientific analytical testing methodologies; medical and scientific research into new drug candidates; industrial analysis and research servicesin particular for selectingcharacterising and preparing immunoglobulinsantibodies or parts thereof; research and development services in the field of immunology; DNA sequencing services being identification of immunogenic sequences and peptides; sequence discovery services in the nature of DNA sequencing technology research; medical and scientific immunotoxicology research and analysis services; medical immunogenicity research and analysis services; pharmaceutical drug development services; development of gene-based medicines; research and development of vaccines and medicines; biological cloning services; biological research and analysis; biological drug development services; laboratory research services relating to pharmaceuticals; providing laboratory research services in the field of biopharmaceuticals; chemicalbiochemicalbiological and bacteriological research and analysis; medical and scientific research and development services in the field of molecular science; medical and scientific analysis services in the field of molecular biology and molecular genetics; diagnostic services in the field of immunology; providing reagent sample testing and diagnostic services for others for scientific research purposes; scientific consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; providing information about medical research in the fields of biopharmaceuticalsimmunologycell engineering and immunoassays; consulting services for others in the field of designplanningimplementation project management of scientific research and clinical trials; custom design and development of chemical reagents and biochemical assays; scientific research in the field of genetics and genetic engineering; genetic sequencing analysis services for scientific and medical research purposes; medical and scientific research services analysing the safety and efficacy of new pharmaceuticals; research in the field of cell engineering technology; cell engineering servicesnamely cell suppression and cell activation; medical and scientific researchdevelopmentengineering and testing services in the fields of bioanalytical assaysassay development and antigen binding; medical and scientific researchdevelopmentengineering and testing services in the fields of immunotherapiesantibody-based molecules and targeted protein degraders; medical and scientific researchdevelopmentengineering and testing services in the fields of molecular biologybiophysicsDNA replication and replication of immune cell interaction in the tumour microenvironment; medical and scientific researchdevelopmentengineering and testing services in the field of biopharmaceutical modulating therapeutics; compiling and analysing data for research purposes in the field of medical science and medical consultancy; authentication of data in the field of immunology; cell culture services for scientific and research purposesfor others; DNA sequencing technology research; medical and scientific researchdevelopmentengineering and testing services in the fields of immunopharmaceuticalsvaccines and oncology; consultancyinformation and advisory services relating to all of the aforesaid services
Publications
History of USPTO decisions and trademark events.
35 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/20/2026
PUBO
PUBLISHED FOR OPPOSITION
01/20/2026
GPNX
NOTIFICATION PROCESSED BY IB
01/15/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/14/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/31/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/17/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/16/2025
GNFR
FINAL REFUSAL E-MAILED
12/16/2025
CNFR
FINAL REFUSAL WRITTEN
12/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/29/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/05/2025
RFNT
REFUSAL PROCESSED BY IB
08/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/16/2025
RFRR
REFUSAL PROCESSED BY MPU
07/15/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/23/2025
CNRT
NON-FINAL ACTION WRITTEN
05/22/2025
DOCK
ASSIGNED TO EXAMINER
05/19/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/01/2025
Continuous trademark protection
Get notified about every new filing that threatens ROUKEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.